These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21362405

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A Critical Domain of Ebolavirus Envelope Glycoprotein Determines Glycoform and Infectivity.
    Fujihira H, Usami K, Matsuno K, Takeuchi H, Denda-Nagai K, Furukawa JI, Shinohara Y, Takada A, Kawaoka Y, Irimura T.
    Sci Rep; 2018 Apr 03; 8(1):5495. PubMed ID: 29615747
    [Abstract] [Full Text] [Related]

  • 3. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.
    J Virol; 2006 Mar 03; 80(6):2738-46. PubMed ID: 16501083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.
    Marzi A, Wegele A, Pöhlmann S.
    Virology; 2006 Sep 01; 352(2):345-56. PubMed ID: 16777170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.
    Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, Lingappa VR, Pöhlmann S.
    J Virol; 2006 Jul 01; 80(13):6305-17. PubMed ID: 16775318
    [Abstract] [Full Text] [Related]

  • 9. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
    Hoffmann M, Crone L, Dietzel E, Paijo J, González-Hernández M, Nehlmeier I, Kalinke U, Becker S, Pöhlmann S.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28228590
    [Abstract] [Full Text] [Related]

  • 10. Epitopes required for antibody-dependent enhancement of Ebola virus infection.
    Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y.
    J Infect Dis; 2007 Nov 15; 196 Suppl 2():S347-56. PubMed ID: 17940970
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
    Ruedas JB, Arnold CE, Palacios G, Connor JH.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021890
    [Abstract] [Full Text] [Related]

  • 20. [Research progress on ebola virus glycoprotein].
    Ding GY, Wang ZY, Gao L, Jiang BF.
    Bing Du Xue Bao; 2013 Mar 01; 29(2):233-7. PubMed ID: 23757858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.